Skip to content
Clinical Trials – home

Terlipressin: A Comprehensive Guide for Patients

0 / 1
trials open to patients / all trials
1+
Countries

In short

Terlipressin is a synthetic vasopressin analog that has been the subject of several clinical trials exploring its potential benefits in treating various medical conditions. This article examines the use of terlipressin in clinical trials for conditions such as portal hypertension, septic shock, hepatorenal syndrome, and surgical procedures like myomectomy. We'll look at how terlipressin compares to other treatments and its effects on patient outcomes.

What is Terlipressin?

Terlipressin is a medication that belongs to a class of drugs called vasopressin analogs. It is a synthetic version of a naturally occurring hormone in the body called vasopressin. Terlipressin is also known by the brand name Glypressin. This medication is primarily used in medical settings to treat certain conditions related to liver disease and bleeding.

Medical Conditions Treated with Terlipressin

Terlipressin is used to treat several medical conditions, including:

  • Hepatorenal Syndrome (HRS): This is a serious kidney problem that can occur in people with advanced liver disease. Terlipressin is used to improve kidney function in patients with a specific type of HRS called HRS-AKI (Acute Kidney Injury).
  • Variceal Bleeding: This is bleeding from enlarged veins in the esophagus or stomach, which can occur in patients with liver cirrhosis (scarring of the liver). Terlipressin is used to stop this type of bleeding.
  • Portal Hypertension: This is high blood pressure in the portal vein, which carries blood from the digestive organs to the liver. Terlipressin can help reduce this pressure.
  • Septic Shock: In some cases, terlipressin is used to treat severe septic shock that doesn't respond to other treatments.

How Terlipressin Works

Terlipressin works by causing blood vessels to constrict or narrow. This action has several effects in the body:

  1. It increases blood pressure, which can be helpful in conditions where blood pressure is too low, such as in septic shock.
  2. In the case of hepatorenal syndrome, it helps improve blood flow to the kidneys, which can improve kidney function.
  3. For variceal bleeding, the constriction of blood vessels can help reduce bleeding from enlarged veins in the digestive tract.
  4. In portal hypertension, terlipressin can help reduce the pressure in the portal vein by constricting blood vessels in the digestive system.

Administration Methods

Terlipressin is typically administered in a hospital setting by healthcare professionals. It can be given in several ways:

  • Intravenous (IV) Bolus: This is a quick injection into a vein.
  • Continuous IV Infusion: The medication is given slowly and continuously through an IV line.
  • Intramyometrial Injection: In some surgical procedures, terlipressin may be injected directly into the muscle of the uterus to reduce bleeding.

The method of administration and dosage will depend on the specific condition being treated and the patient's individual needs.

Clinical Trials and Research

Terlipressin is the subject of ongoing research to better understand its effects and potential uses. Some areas of current research include:

  • Comparing continuous infusion versus bolus injection of terlipressin for treating portal hypertension-related bleeding in liver cirrhosis.
  • Evaluating the use of terlipressin in liver transplant candidates with hepatorenal syndrome.
  • Investigating the effects of terlipressin on portal vein pressure in patients after liver tumor surgery.
  • Studying the use of terlipressin in managing potential organ donors to improve organ function for transplantation.

Side Effects and Precautions

Like all medications, terlipressin can cause side effects. Some potential side effects include:

  • Abdominal pain
  • Diarrhea
  • Headache
  • High blood pressure
  • Low sodium levels in the blood (hyponatremia)

Terlipressin should only be used under close medical supervision. It's important for patients to inform their healthcare providers about all medications they are taking and any existing medical conditions, especially heart or blood vessel problems.

In conclusion, terlipressin is a powerful medication used primarily in hospital settings to treat serious conditions related to liver disease and bleeding. While it can be very effective, it requires careful administration and monitoring by healthcare professionals.

Questions people often ask

Conditions where Terlipressin is being studied

Each condition opens its own overview and trial list

Trials with Terlipressin

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).